selected publications
- Affinity Selection-Mass spectrometry coupled with biophysical validation enables proof-of-concept discovery of CHI3L1 binders. Biochemical and biophysical research communications. 2025 Academic Article GET IT
- Structure-Based Virtual Screening Identifies TREM2-Targeted Small Molecules that Enhance Microglial Phagocytosis. 2025 GET IT
- Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma Therapy. 2025 GET IT
- Virtual Screening-Guided Discovery of Small Molecule CHI3L1 Inhibitors with Functional Activity in Glioblastoma Spheroids. 2025 GET IT
- TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapy. Trends in pharmacological sciences. 2025 Review GET IT
- CHI3L1-targeted small molecules as glioblastoma therapies: Virtual screening-based discovery, biophysical validation, pharmacokinetic profiling, and evaluation in glioblastoma spheroids. European journal of medicinal chemistry. 2025 Academic Article GET IT
- Lead optimization of a CHI3L1 inhibitor for Glioblastoma: Enhanced target engagement, pharmacokinetics, and efficacy in 3D spheroid models. European journal of medicinal chemistry. 2025 Academic Article GET IT
- CD28 and ICOS in immune regulation: Structural insights and therapeutic targeting. Bioorganic & medicinal chemistry letters. 2025 Review GET IT
- CHI3L1-Targeted Small Molecules as Glioblastoma Therapies: Virtual Screening-Based Discovery, Biophysical Validation, Pharmacokinetic Profiling, and Evaluation in Glioblastoma Spheroids. 2025 GET IT
- Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors. Advances in pharmacology (San Diego, Calif.). 2024 Review GET IT
- Retraction notice to "Thermostable xylanases from thermophilic fungi and bacteria: Current perspective" [Bioresour. Technol. 277 (2019) 195-203]. Bioresource technology. 2024 Academic Article GET IT
- Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome. ACS chemical neuroscience. 2024 Academic Article GET IT
-
Developing endophytic Penicillium oxalicum as a source of lignocellulolytic enzymes for enhanced hydrolysis of biorefinery relevant pretreated rice straw.
Bioprocess and biosystems engineering.
2024
Academic Article
GET IT
Times cited: 1 -
Genome and secretome insights: unravelling the lignocellulolytic potential of Myceliophthora verrucosa for enhanced hydrolysis of lignocellulosic biomass.
Archives of microbiology.
2024
Academic Article
GET IT
Times cited: 5 - Small Peptides Targeting BACE-1, AChE, and A-β Reversing Scopolamine-Induced Memory Impairment: A Multitarget Approach against Alzheimer's Disease. ACS omega. 2024 Academic Article GET IT
-
Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold.
Journal of medicinal chemistry.
2023
Academic Article
GET IT
Times cited: 9 -
A patent review of NLRP3 inhibitors to treat autoimmune diseases.
Expert opinion on therapeutic patents.
2023
Review
GET IT
Times cited: 10 -
Alzheimer's Disease: Treatment of Multi-Factorial Disorders with Multi- Target Approach.
Mini reviews in medicinal chemistry.
2023
Academic Article
GET IT
Times cited: 2 -
Proline based rationally designed peptide esters against dipeptidyl peptidase-4: Highly potent anti-diabetic agents.
Bioorganic & medicinal chemistry letters.
2022
Academic Article
GET IT
Times cited: 4 -
Lignocellulolytic enzymes from Aspergillus allahabadii for efficient bioconversion of rice straw into fermentable sugars and biogas.
Bioresource technology.
2022
Academic Article
GET IT
Times cited: 20 -
Epoxides: Developability as active pharmaceutical ingredients and biochemical probes.
Bioorganic chemistry.
2022
Review
GET IT
Times cited: 32